Not exact matches
As such, changes in fair value are recognized in income, including
fluctuations due to the
exchange rate between the New Taiwan
Dollar and the United States
Dollar.
The logistics turned out to be relatively simple: The chain spent roughly $ 60 per store on signage and opted to fix the
exchange rate at 12 pesos to the
dollar — slightly higher than the going rate — to cover any market
fluctuations and banking fees.
But Siracusano of WisdomTree reminds U.S. - based investors that
exchange - rate
fluctuations could erode returns if, say, the euro plunges further against the
dollar.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued
fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause
fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause
fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions;
fluctuations in the foreign
exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
exchange rate of the U.S.
dollar that may cause an unfavorable foreign currency
exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and
Exchange Commission (t
Exchange Commission (the SEC).
Exchange rates are relative prices and to understand
dollar fluctuations one has to look at what has happened in the US as well as other countries.
Fluctuations in the
exchange rates between the U.S.
dollar and those other currencies could result in the
dollar equivalent of such expenses being higher and / or the
dollar equivalent of such foreign - denominated revenue being lower than would be the case if
exchange rates were stable.
Accordingly,
fluctuations in foreign currency
exchange rates, most notably the strengthening of the U.S.
dollar against the
What's funny about it is that you can get about 5 - 10 million
dollars more or less, all because of
fluctuations in the
exchange rate, which is a normal thing for Bitcoin.
Exchange traded funds, such as the iShares Currency Hedged MSCI EMU ETF (HEZU) and the iShares Currency Hedged MSCI Germany ETF (HEWG), can provide access to the eurozone market and Germany, respectively, while potentially mitigating exposure to
fluctuations between the value of the euro and the U.S.
dollar.
Prices are subject to change without prior notice due to the
dollar fluctuation exchange rates.
CC: Do you make any attempt to account for currency
fluctuations (ie: If $ US appears to be on upward or downward trajectory - some still think the day of reckoning has not come for the US and its
dollar) or is F / X risk just part and parcel of your foreign holdings and your global diversification accounts for portfolio allocation and
exchange risk?
dollars, which exposes you to
dollar fluctuations and bank
exchange fees.
Visa sets the rate daily for buying pesos, but prices for
dollars may fluctuate modestly at the
exchange houses over the course of a day.Thus, most or all of the spread is likely not due to currency
fluctuations.
Even if the U.S.
dollars falls you should be protected if the foreign currency moves upward with the Canadian
dollar as you mention in this post: «You can essentially ignore the CAD - USD
fluctuation for broad international ETFs like Vanguard Europe Pacific ETF (VEA), iShares MSCI EAFE ETF (EFA), Vanguard Emerging Markets ETF (VWO), iShares MSCI Emerging Markets ETF (EEM) etc., country - specific ETFs like iShares MSCI Japan ETF (EWJ), iShares MSCI Australia ETF (EWA) etc. and even ADRs that trade in US
exchanges but are denominated in local currencies like Nokia (NOK)».
Securities denominated in currencies other than U.S.
dollars are subject to changes in value due to
fluctuation in
exchange rates.
Global currency trading involves trillions of
dollars to make profits from
fluctuations in
exchange rates and in speculating on currency variations.
Fluctuations in the
exchange rate can clearly have an impact on your Canadian
dollar returns.
Three lawyers indicated to us that their banks asked them to make up losses due to
exchange rate
fluctuations on US
dollar cashier's cheques they deposited that turned out to be counterfeit.
After acquiring an American pharmacy chain in 2004, the Applicant, Le Groupe Jean Coutu (PJC) inc., was faced with a problem with the accounting presentation of its American investment because of
fluctuations in the
exchange rate between the U.S. and Canadian
dollars.
The Jordanian dinar has been pegged to the US
dollar at a rate of 0.709 dinar per
dollar since 1995, with only very small
fluctuations in the
exchange rate seen during that period.